51079-555 : Repaglinide 2 mg/1 Oral Tablet


NDC51079-555
Labeler: Mylan Institutional Inc.
Product Type: Human Prescription Drug
Drug Name:  Repaglinide
Dosage Form: Oral Tablet
Application #: ANDA090252
Rev. Date: 


Appearance:


Markings: M;R23
Shapes:  Round
Colors:  Green
Size (mm): 6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 51079-555-03: 30 BLISTER PACK IN 1 BOX, UNIT‑DOSE (51079‑555‑03) > 1 TABLET IN 1 BLISTER PACK (51079‑555‑01)

Active Ingredients:

  • Repaglinide

Dosage Strength:

  • 2 mg

Inactive Ingredients:

  • Butylated Hydroxyanisole
  • Silicon Dioxide
  • Starch, Corn
  • Croscarmellose Sodium
  • Calcium Phosphate, Dibasic, Anhydrous
  • Magnesium Stearate
  • Meglumine
  • Cellulose, Microcrystalline
  • Polacrilin Potassium
  • Povidones
  • Sodium Lauryl Sulfate
  • Fd&c Blue No. 1
  • D&c Yellow No. 10

Pharmaceutical Classes:

  • Glinide [EPC]
  • Potassium Channel Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 51079-062 Repaglinide .5 mg/1 Oral Tablet by Mylan Institutional Inc.
  • 51079-539 Repaglinide 1 mg/1 Oral Tablet by Mylan Institutional Inc.
  • 0378-3121 Repaglinide 0.5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-3122 Repaglinide 1 mg/1 Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-3123 Repaglinide 2 mg/1 Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0574-0240 Repaglinide 0.5 mg Oral Tablet by Paddock Laboratories, LLC
  • 0574-0241 Repaglinide 1 mg/1 Oral Tablet by Paddock Laboratories, LLC
  • 0574-0242 Repaglinide 2 mg/1 Oral Tablet by Paddock Laboratories, LLC
  • 0781-5148 Repaglinide .5 mg/1 Oral Tablet by Sandoz Inc
  • 0781-5149 Repaglinide 1 mg/1 Oral Tablet by Sandoz Inc
  • 0781-5150 Repaglinide 2 mg/1 Oral Tablet by Sandoz Inc
  • 42291-719 Repaglinide 1 mg/1 Oral Tablet by Avkare, Inc.
  • 42291-720 Repaglinide 2 mg/1 Oral Tablet by Avkare, Inc.
  • 51991-853 Repaglinide .5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-854 Repaglinide 1 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-855 Repaglinide 2 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 57237-157 Repaglinide .5 mg Oral Tablet by Citron Pharma LLC
  • 57237-158 Repaglinide 1 mg Oral Tablet by Citron Pharma LLC
  • 57237-159 Repaglinide 2 mg Oral Tablet by Citron Pharma LLC
  • 57664-745 Repaglinide 1 mg Oral Tablet by Caraco Pharmaceutical Laboratories, Ltd.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 51079-555 QR Code

< Prev: 51079-550Next: 51079-557 >

Related Discussions:

Prandimet(metformin and repaglinide
specify availability of Prandimet(metformin and repaglinide) in india....




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 December 2015.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA